Copyright: ©Author(s) 2026.
World J Gastroenterol. Apr 7, 2026; 32(13): 114657
Published online Apr 7, 2026. doi: 10.3748/wjg.v32.i13.114657
Published online Apr 7, 2026. doi: 10.3748/wjg.v32.i13.114657
Figure 4 Metabolic dysfunction-associated steatohepatitis in lean vs non-lean metabolic dysfunction-associated steatotic liver disease.
MASH: Metabolic dysfunction-associated steatohepatitis; MASLD: Metabolic dysfunction-associated steatotic liver disease; CI: Confidence interval.
- Citation: Mapouka M, Pabingui E, Tazinkeng NN, Gurmessa M, Vickos U, Ndemazie NB, Camengo Police SM. Outcomes of liver and cardiovascular metabolic diseases among lean vs non-lean individuals with metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2026; 32(13): 114657
- URL: https://www.wjgnet.com/1007-9327/full/v32/i13/114657.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i13.114657